A detailed history of Impact Capital Partners LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Impact Capital Partners LLC holds 2,287 shares of CRL stock, worth $365,668. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,287
Holding current value
$365,668
% of portfolio
0.15%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$178.58 - $220.69 $408,412 - $504,718
2,287 New
2,287 $422 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.13B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Impact Capital Partners LLC Portfolio

Follow Impact Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Impact Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Impact Capital Partners LLC with notifications on news.